For the year ending 2025-12-31, KRRO made $6,392K in revenue. -$117,316K in net income. Net profit margin of -1835.36%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Collaboration revenue | 6,392 | |||
| Research and development | 65,575 | |||
| General and administrative | 28,159 | |||
| Long-lived asset impairment charge | 30,886 | |||
| Restructuring charge | 3,627 | |||
| Total operating expenses | 128,247 | |||
| Loss from operations | -121,855 | |||
| Other income, net | 5,232 | |||
| Total other income, net | 5,232 | |||
| Loss before provision for income taxes | -116,623 | |||
| Provision for income taxes | 637 | |||
| Net loss | -117,260 | |||
| Unrealized (loss) gain on available-for-sale marketable securities | -26 | |||
| Foreign currency translation adjustments, net | 30 | |||
| Comprehensive loss | -117,316 | |||
| Basic EPS | -12.48 | |||
| Diluted EPS | -12.48 | |||
| Basic Average Shares | 9,395,402 | |||
| Diluted Average Shares | 9,395,402 | |||
Korro Bio, Inc. (KRRO)
Korro Bio, Inc. (KRRO)